Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
PRNewsWire
·
2026-05-01
·
via The Tech Buzz - Press Releases
SUNRISE-II feasibility trial marks the company's entry into U.S. clinical development, advancing minimally invasive, anesthesia-free treatment approach PALO ALTO, Calif., May 1, 2026 /PRNewswire/ -- S
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。